Hematologic Oncology Update cover image

Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Hematologic Oncology Update

CHAPTER

Innovations in CAR T-Cell Therapies for Myeloma

This chapter explores the intricacies of CAR T-cell therapies, specifically Idacel and Siltacel, in treating multiple myeloma. It highlights key differences in efficacy, binding mechanisms, and response rates based on trial data, while addressing ongoing research and the risks of toxicity. Additionally, the chapter emphasizes the importance of therapy sequencing and its impact on patient outcomes, using real case studies to illustrate these complexities.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner